紫杉醇白蛋白结合型联合卡铂一线治疗晚期非小细胞肺癌合并肾功能损伤患者的成本效果分析
戴冰, 李昊, 占美, 田方圆, 徐珽, 蒋学华
Cost-effectiveness analysis of nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced none small-cell lung cancer and renal impairment
DAI Bing, LI Hao, ZHAN Mei, TIAN Fang-yuan, XU Ting, JIANG Xue-hua
中国医院药学杂志
.
2020, (24): 2526
-2530
.
DOI: 10.13286/j.1001-5213.2020.24.05
